Peresolimab: Phase 2 Study for Rheumatology Treatment

2023-05-18 09:14:28

Rheumatology
–

Phase 2 study

The monoclonal antibody peresolimab restores the immune checkpoint in rheumatoid arthritis.

Biomarkers and predictive factors for rheumatoid arthritis continue to be studied. (ILLUSTRATION: Gabriel Sanz)

1684401403
#explore #checkpoint #route #treat #rheumatoid #arthritis